|
|
| (20 intermediate revisions not shown) |
| Line 1: |
Line 1: |
| - | <html>
| |
| - | <head>
| |
| - | <script src="http://ajax.googleapis.com/ajax/libs/jquery/1.10.2/jquery.min.js">
| |
| - | </script>
| |
| - | <script type="text/javascript">
| |
| - | $(document).ready(function(){
| |
| - | $("ul.first > li").hover(function(){
| |
| - | $(this).find("ul").stop().fadeToggle(10);
| |
| - | });
| |
| - | });
| |
| - | </script>
| |
| - | <script>
| |
| - | $(document).ready(function(){
| |
| | | | |
| - | // hide #back-top first
| |
| - | $("#back-top").hide();
| |
| - |
| |
| - | // fade in #back-top
| |
| - | $(function () {
| |
| - | $(window).scroll(function () {
| |
| - | if ($(this).scrollTop() > 100) {
| |
| - | $('#back-top').fadeIn();
| |
| - | } else {
| |
| - | $('#back-top').fadeOut();
| |
| - | }
| |
| - | });
| |
| - |
| |
| - | // scroll body to 0px on click
| |
| - | $('#back-top a').click(function () {
| |
| - | $('body,html').animate({
| |
| - | scrollTop: 0
| |
| - | }, 800);
| |
| - | return false;
| |
| - | });
| |
| - | });
| |
| - |
| |
| - | });
| |
| - | </script>
| |
| - | <script>
| |
| - | $(document).ready(function()
| |
| - | {
| |
| - | $('#menubar').mouseover(function(){
| |
| - | $('#menubar').stop().animate({top:"0px"},500);
| |
| - | });
| |
| - | $('#menubar').mouseleave(function(){
| |
| - | $('#menubar').stop().animate({top:"-20px"},500);
| |
| - | });
| |
| - | $('#menubar.right-menu').mouseover(function(){
| |
| - | $('#menubar.right-menu').stop().animate({top:"0px"},500);
| |
| - | });
| |
| - | $('#menubar.right-menu').mouseleave(function(){
| |
| - | $('#menubar.right-menu').stop().animate({top:"-20px"},500);
| |
| - | });
| |
| - | });
| |
| - | </script>
| |
| - | <style type="text/css">
| |
| - | body{background-color:#d5cfbf;width:100%;margin-bottom:20px;min-width:600px;max-width:2000px;font: x-small sans-serif;}
| |
| - | #menubar
| |
| - | {background-color:#EEECEC;opacity:0.8;top:-4px;width:360px;height:23px;position:absolute;top:-20px;}
| |
| - | #menubar ul li a
| |
| - | { color:#8D1919;}
| |
| - | #menubar.right-menu
| |
| - | {background-color:#EEECEC;opacity:0.8;top:-4px;width:240px;height:23px;position:absolute;top:-20px;}
| |
| - | .right-menu li a
| |
| - | {color:#8D1919;background-color:#EEECEC;}
| |
| - | #p-logo
| |
| - | {visibility:hidden;}
| |
| - | .firstHeading
| |
| - | {visibility:hidden;}
| |
| - | #globalWrapper
| |
| - | {position: relative;font-size:127%;width:100%;margin:0;padding:0;padding-bottom:10px;background-color:#494042;height:3500px;}
| |
| - | #content
| |
| - | {width: 1000px;border:none;background-color:#ffffff;height:3400px;padding:0px;margin-top:0px;line-height: 1.5em;color: black;}
| |
| - | #top-section
| |
| - | {height:2px;border:none;background-color:#494042;}
| |
| - | #catlinks
| |
| - | {display:none;}
| |
| - | #footer-box
| |
| - | {display:none}
| |
| - | #kepala
| |
| - | {position:absolute;top:15px;background-color:#F0A5BE;}
| |
| - | #cover
| |
| - | {position:absolute;top:0px;height:168px;width:100%;background:#494042;z-index:-1;}
| |
| - | body, div, dl, dt, dd, ul, ol, li, h1, h4, h6, pre, form, fieldset, p, blockquote, th, td {
| |
| - | margin: 0;
| |
| - | padding: 0;
| |
| - | font-size: 14px;
| |
| - | }
| |
| - | * {
| |
| - | -webkit-box-sizing: border-box;
| |
| - | -moz-box-sizing: border-box;
| |
| - | box-sizing: border-box;
| |
| - | }
| |
| - | div.menu
| |
| - | {
| |
| - | width:100%;
| |
| - | }
| |
| - | .row {
| |
| - | width: 940px;
| |
| - | max-width: 100%;
| |
| - | min-width: 768px;
| |
| - | margin: 0 auto;
| |
| - |
| |
| - | }
| |
| - | .row:after {
| |
| - | clear: both;
| |
| - | }
| |
| - | .row:before, .row:after {
| |
| - | content: "";
| |
| - | display: table;
| |
| - | }
| |
| - | .menu ul,li
| |
| - | {
| |
| - | margin:0;
| |
| - | padding:0;
| |
| - | list-style:none;
| |
| - | width:100%;
| |
| - | }
| |
| - | ul.first>li
| |
| - | {
| |
| - | float:left;
| |
| - | width:16.667%;
| |
| - | }
| |
| - | ul.first>li>a:link,ul.first>li>a:visited
| |
| - | {
| |
| - | display:block;
| |
| - | font-weight:bold;
| |
| - | color:#494042;
| |
| - | background-color:#35bb91;
| |
| - | text-align:center;
| |
| - | padding:3%;
| |
| - | text-decoration:none;
| |
| - | text-transform:uppercase;
| |
| - | }
| |
| - |
| |
| - | ul.first>li>a:hover,ul.first>li>a:active
| |
| - | {
| |
| - | background-color:#e32e51;
| |
| - | }
| |
| - |
| |
| - | ul.first>li>ul
| |
| - | {
| |
| - | display:none;
| |
| - | width:100%;
| |
| - | }
| |
| - |
| |
| - | ul.first>li>ul>li>a:link,ul.first>li>ul>li>a:visited
| |
| - | {
| |
| - | display:block;
| |
| - | font-weight:bold;
| |
| - | color:#494042;
| |
| - | background-color:#8ff5d5;
| |
| - | text-align:center;
| |
| - | padding:3%;
| |
| - | text-decoration:none;
| |
| - | text-transform:uppercase;
| |
| - | }
| |
| - |
| |
| - | ul.first>li>ul>li>a:hover,ul.first>li>ul>li>a:active
| |
| - | {
| |
| - | background-color:#f87790;
| |
| - | }
| |
| - | .menu
| |
| - | {
| |
| - | position:absolute;
| |
| - | left:0px;
| |
| - | top:141px;
| |
| - | width:100%;
| |
| - | }
| |
| - | #back-top {
| |
| - | position: fixed;
| |
| - | top: 10%;
| |
| - | right: 2%;
| |
| - | }
| |
| - | #back-top a {
| |
| - | width: 108px;
| |
| - | display: block;
| |
| - | text-align: center;
| |
| - | font: 11px/100% Arial, Helvetica, sans-serif;
| |
| - | text-transform: uppercase;
| |
| - | text-decoration: none;
| |
| - | color: #bbb;
| |
| - | /* background color transition */
| |
| - | -webkit-transition: 1s;
| |
| - | -moz-transition: 1s;
| |
| - | transition: 1s;
| |
| - | }
| |
| - | #back-top a:hover {
| |
| - | color: #ffffff;
| |
| - | }
| |
| - |
| |
| - | #back-top span {
| |
| - | width: 65px;
| |
| - | height: 60px;
| |
| - | display: block;
| |
| - | margin-bottom: 7px;
| |
| - | background: #ddd url(up-arrow.png) no-repeat center center;
| |
| - | /* rounded corners */
| |
| - | -webkit-border-radius: 15px;
| |
| - | -moz-border-radius: 15px;
| |
| - | border-radius: 15px;
| |
| - | /* background color transition */
| |
| - | -webkit-transition: 1s;
| |
| - | -moz-transition: 1s;
| |
| - | transition: 1s;
| |
| - | }
| |
| - | #back-top a:hover span {
| |
| - | background-color: #777;margin-top:10px;
| |
| - | }
| |
| - |
| |
| - | ul.side-nav, ul.side-nav1 {
| |
| - | display: block;
| |
| - | list-style: none;
| |
| - | margin: 0;
| |
| - | padding: 17px 0;font-family:"Trebuchet MS", Helvetica, sans-serif;
| |
| - | }
| |
| - | ul.side-nav h6 {
| |
| - | margin: 47px 0px 0px;
| |
| - | }
| |
| - | ul.side-nav1 h6 {
| |
| - | margin: 0px 0px 0px;
| |
| - | }
| |
| - | ul.side-nav li.divider, ul.side-nav1 li.divider {
| |
| - | border-top: 1px solid #ddd;
| |
| - | }
| |
| - |
| |
| - | .two, .row .two {
| |
| - | width: 16.66667%;
| |
| - | top:160px;
| |
| - | }
| |
| - | ul, ol {
| |
| - | font-size: 14px;
| |
| - | line-height: 1.6;
| |
| - | }
| |
| - | [class*="column"] + [class*="column"]:last-child {
| |
| - | float: right;
| |
| - | }
| |
| - | .ten, .row .ten {
| |
| - | width: 83.33333%;
| |
| - | top:192px;
| |
| - | z-index:-2;
| |
| - | }
| |
| - | .column, .columns {
| |
| - | float: left;
| |
| - | min-height: 1px;
| |
| - | padding: 0 15px;
| |
| - | position: relative;
| |
| - | }
| |
| - | .twelve, .row .twelve {
| |
| - | width: 100%;
| |
| - | }
| |
| - | h1, h2, h4, h5, h6 {
| |
| - | font-family:"Trebuchet MS", Helvetica, sans-serif;
| |
| - | font-weight: normal;
| |
| - | color: #000;
| |
| - | border-bottom: none;
| |
| - |
| |
| - |
| |
| - | h3{font-size:18px;font-family:"Trebuchet MS", Helvetica, sans-serif;}
| |
| - | h5{margin-left:15px;}
| |
| - |
| |
| - | }
| |
| - | div.team-bios-container div.row {
| |
| - | padding: 0px 0px 10px;
| |
| - | border-bottom: 1px solid #ddd;
| |
| - | }
| |
| - | .row .row {
| |
| - | width: auto;
| |
| - | max-width: none;
| |
| - | min-width: 0;
| |
| - | margin: 0 -15px;
| |
| - | }
| |
| - | media="screen, projection"
| |
| - | #bodyContent h1, #bodyContent h2 {
| |
| - | margin-bottom: .6em;
| |
| - | }
| |
| - | h1.centered, h2.centered, h3.centered, h4.centered, h5.centered, h6.centered {
| |
| - | text-align: center;
| |
| - | }
| |
| - | h2 {
| |
| - | font-size: 37px;
| |
| - | }
| |
| - | .nine, .row .nine {
| |
| - | width: 100%;font-family:"Trebuchet MS", Helvetica, sans-serif;
| |
| - | }
| |
| - | [class*="column"] + [class*="column"]:last-child {
| |
| - | float: right;
| |
| - | }
| |
| - | .three, .row .three {
| |
| - | width: 25%;
| |
| - | }
| |
| - | #construct{margin-left:30px;}
| |
| - | ul li ul, ul li ol {
| |
| - | margin-left: 20px;
| |
| - | margin-bottom: 0;}
| |
| - | </style>
| |
| - |
| |
| - | <body>
| |
| - | <p id="back-top" style=""display:none;>
| |
| - | <a href="#top"><span><img src="http://515alive.com/theme/img/up-arrow.png" style="width:90%;"><br><br>BACK TO TOP</span></a>
| |
| - | </p>
| |
| - | <a href=https://2013.igem.org/Team:Hong_Kong_HKUST><center><div id="kepala" style="height:121px;width:100%;"><img src="https://static.igem.org/mediawiki/igem.org/c/c7/BANNER1_%281%29.png" style="height:121px;width:100%;align:middle;"></div></center></a>
| |
| - | <div id="cover"></div>
| |
| - | <div class="menu">
| |
| - | <ul class="first">
| |
| - |
| |
| - | <li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST">Home</a></li>
| |
| - |
| |
| - | <li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/team">Team</a>
| |
| - | <ul>
| |
| - | <li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/members">Members</a></li>
| |
| - | <li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/advisors">Advisors</a></li>
| |
| - | <li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/instructors">Instructors</a></li>
| |
| - | <li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/attribution">Attribution</a></li>
| |
| - | <li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/acknowledge">Acknowledgement</a></li>
| |
| - | </ul>
| |
| - | </li>
| |
| - |
| |
| - | <li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/Project">Project</a>
| |
| - | <ul>
| |
| - | <li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/abstract">Abstract</a></li>
| |
| - | <li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/modules">Modules Description</a></li>
| |
| - | <li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/Parts">Parts</a></li>
| |
| - | <li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/characterization">Characterization</a></li>
| |
| - | <li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/modelling">Modeling</a></li>
| |
| - | <li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/results">Result</a></li>
| |
| - | </ul>
| |
| - | </li>
| |
| - |
| |
| - | <li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/Wetlab">Wetlab</a>
| |
| - | <ul>
| |
| - | <li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/notebook">Notebook</a></li>
| |
| - | <li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/protocols">Protocols</a></li>
| |
| - | <li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/safety">Safety</a></li>
| |
| - | <li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/future">Future Work</a></li>
| |
| - | </ul>
| |
| - | </li>
| |
| - |
| |
| - | <li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/achievement">Achievement</a>
| |
| - | <ul>
| |
| - | <li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/medals">Medal Requirements</a></li>
| |
| - | <li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/prizes">Prizes</a></li>
| |
| - | </ul>
| |
| - | </li>
| |
| - |
| |
| - | <li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/hp">Human Practice</a>
| |
| - | <ul>
| |
| - | <li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/hp/interview">Interviews</a></li>
| |
| - | <li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/hp/cp">Country Profile</a></li>
| |
| - | <li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/hp/blog">Blog</a></li>
| |
| - | <li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/hp/article">Article</a></li>
| |
| - | <li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/hp/video">Videos</a></li>
| |
| - | <li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/hp/presentation">Presentations</a></li>
| |
| - | </ul>
| |
| - | </li>
| |
| - |
| |
| - | </ul>
| |
| - |
| |
| - | </div>
| |
| - | </div>
| |
| - | <div class="row">
| |
| - | <div class="two columns">
| |
| - | <ul class="side-nav">
| |
| - | <li>
| |
| - | <h6>FA Quantification & Cell Viability</h6>
| |
| - | </li>
| |
| - | <li class="divider"></li>
| |
| - | <li>
| |
| - | <a href=#1>Cell Line</a>
| |
| - | </li>
| |
| - | <li>
| |
| - | <a href=#2>Cell Culture</a>
| |
| - | </li>
| |
| - | <li>
| |
| - | <a href=#3>Cell Viability</a>
| |
| - |
| |
| - | </li>
| |
| - | <li>
| |
| - | <a href=#4>Fatty Acid Quantification</a>
| |
| - |
| |
| - | </li>
| |
| - |
| |
| - | </ul>
| |
| - | <ul class="side-nav1">
| |
| - | <li>
| |
| - | <h6>Modules</h6>
| |
| - | </li>
| |
| - | <li class="divider"></li>
| |
| - | <li>
| |
| - | FA Quantification & Cell Viability
| |
| - | </li>
| |
| - | <li>
| |
| - | <a href="https://2013.igem.org/Team:Hong_Kong_HKUST/Project/module2">FA Sensing Mechanism</a>
| |
| - | </li>
| |
| - | <li>
| |
| - | <a href="https://2013.igem.org/Team:Hong_Kong_HKUST/Project/module3">Protein Trafficking</a>
| |
| - | </li>
| |
| - | <li>
| |
| - | <a href="https://2013.igem.org/Team:Hong_Kong_HKUST/Project/module4">Glyoxylate Shunt</a>
| |
| - | </li>
| |
| - | </ul>
| |
| - | </div>
| |
| - | <div class="ten columns team-bios-container">
| |
| - | <div class="row" id="ugd-members">
| |
| - | <div class="twelve columns">
| |
| - | <br>
| |
| - | <h2 class="centered">Fatty Acid Quantification and Cell Viability</h2>
| |
| - | </div>
| |
| - | </div>
| |
| - | <div class="row">
| |
| - | <div class="nine columns"><p id="1"></p>
| |
| - | <h3>Cell Line</h3>
| |
| - | For our project we made use of two mammalian cell lines: HepG2 human hepatoma cell (HepG2 cell) and human embryonic kidney 293 cell (HEK293FT). HepG2 cell was used for characterizing inducible promoters and glyoxylate systems. For higher transfection efficiency, the characterizations of mitochondria leader sequence and constitutive promoter were conducted using HEK293FT cells.
| |
| - | <br>
| |
| - | </div>
| |
| - | </div>
| |
| - | <div class="row">
| |
| - | <div class="nine columns"><p id="2"></p>
| |
| - | <h3>Cell Culture</h3>
| |
| - | HepG2 and HEK293FT cells were maintained in DMEM supplemented with 10% heat-inactivated FBS and 50ug/mL penicillin, 50ug/mL streptomycin at 37℃in a humidified atmosphere containing 5% CO2. Cells were transfected in petri dishes and multi-well plates with different construct Lipofectamine 2000 (Invitrogen; Carlsbard, CA) according to manufacturer’s protocols. Any GFP signals were observed under fluorescent microscope or under confocal microscope if necessary.
| |
| - | </div>
| |
| - | </div>
| |
| - | <div class="row">
| |
| - | <div class="nine columns"><p id="3"></p>
| |
| - | <h3>Cell Viability</h3>
| |
| - | We designed to introduce an inducible system that allows tunable fatty acid uptake by sensing fatty acid concentrations. Fatty acids uptake was to be quantified to compare the activities of wild type cells and cells expressing inducible glyoxylate shunt.
| |
| - | <br><br>
| |
| - | To facilitate expression of inducible glyoxylate shunt in human hepatoma cell line (HepG2 cell), cell viability at different sodium palmitate concentration was measured. While a high fatty acid level is known to lead apoptosis, the cell viability test ensured maintenance of a stable cell line for transfection.<br><br>
| |
| - | We used MTT assay to test cell viabilities in different fatty acid concentrations. The objective was to determine a range of optimal concentrations of fatty acids to be introduced into HepG2 cell and achieve more than 60% viability after 24 hours incubation and/or more than 50% in 48 hours.<br><br>
| |
| - |
| |
| - | <h5><b>MTT assay description</b></h5>
| |
| - | CMTT assay measures the enzymatic activity of oxidoreductase enzymes that only show activity when the cells are alive. MTT, a tetrazolum dye, is reduced into an insoluble formazan, giving a purple color. Organic solvent such as DMSO can be used to dissolve the formazan. Absorbance at 570 is measured using a spectrophotometer to quantitatively determine the amount of formazan formation.<br><br>
| |
| - | In our experiment, HepG2 cells were seeded into a 96-well plate. After one day incubation gradient concentration of sodium palmitate from 0 mM to 1.0mM, and 2.0mM were added into each row. After adding the sodium palmitate, we have incubated the cells for 24 hours and 48 hours respectively. MTT reagent was added and formazan formation was observed and measured using spectrophotometer.
| |
| - |
| |
| - | <br><br>
| |
| - | <h5><b>Results</h5></b>
| |
| - | From the MTT assay, we observed that after 24 hours of incubation with palmitic acid, around 45% of cell viability can be maintained even at 2.0mM. For 48 hours incubation, cell viability varied for different concentrations. To maintain 50% cell viability after 48 hours incubation with palmitic acid, we concluded to experiment within range from 0mM to 0.32 mM of palmitic acid. Click on the pictures beside for a detailed result on cell viability.
| |
| - | <br>
| |
| - | </div>
| |
| - | </div>
| |
| - | <div class="row">
| |
| - | <div class="nine columns"><p id="4"></p>
| |
| - | <h3>Fatty Acid Quantification</h3>
| |
| - | Two fatty acid quantification methods were investigated to measure fatty acid uptake rate of constitutive and inducible glyoxylate system: 1) Gas Chromatography-Mass Spectrophotometry (GC-MS), and 2) Fatty acid quantification kit (Sigma Aldrich). While we managed to measure fatty acid amount in cell culture medium using GC-MS, fatty acid quantification kit could not be tested due to limitation of time.<br><br>
| |
| - | <h5><b>Fatty Acid Treatment</b></h5>
| |
| - | In measuring fatty acid, fatty acid solution was mixed with ethanol and chloroform. After acidifying by HCl and refluxing in water bath for 30 min, the organic layer containing fatty acid was collected and extracted by diethyl ether and petroleum ether solution. Again the organic layer was sucked out to be dried before NaOH was added. Then after derivatisation by BF3 and bromotetradecane, the organic layer was collected into GC-MS vial for analysis.
| |
| - | <br><br>
| |
| - | <h5><b>GC-MS</b></h5>
| |
| - | GC-MS is a very useful tool to quantify volatile compounds effectively. For our experiment, we conducted calibration test using known concentrations of fatty acids. However, it was difficult to reach a conclusion due to lack of internal standards and uncertain amount of sample loss for<br>
| |
| - |
| |
| - |
| |
| - | </div>
| |
| - | </div>
| |
| - | </div>
| |
| - | </body>
| |
| - | </html>
| |
"
